Franklin Covey Posts $70.0M Q4 Revenue, Guides FY2027 to $263M-$273M
FC sits 51% above its 52-week low of $11.16.
Summary
Franklin Covey closed FY2026 with $70.0 million of Q4 revenue inside guidance and 9% higher Q4 Adjusted EBITDA, then guided FY2027 to $263-$273 million of revenue and $29-$34 million of Adjusted EBITDA.
Key Events · Earnings and Guidance · FC
-
Q4 Revenue In Line, Profit Jumps
Q4 FY2026 revenue was $70.0 million versus $71.2 million a year earlier, while net income rose to $7.1 million, or $0.62 per diluted share, from $4.4 million, or $0.34.
-
FY2027 Guidance Issued
Revenue guided to $263-$273 million and Adjusted EBITDA to $29-$34 million; the $31.5 million EBITDA midpoint is about 9% above FY2026's $28.9 million on roughly 2.5% revenue growth at the $268 million midpoint.
-
Deferred Revenue Builds
Consolidated deferred revenue rose 4% to $116.1 million; Enterprise Division deferred revenue rose 14% to $64.9 million and Enterprise North America 17% to $59.2 million.
-
China Moves to Licensee Model
Direct China operations shift to a locally owned licensee, expected to close by the end of Q2 FY2027, cutting FY2027 reported revenue by about $2.0 million with no material Adjusted EBITDA impact.
Analysis · FC · Trade & Services
Q4 revenue of $70.0 million landed inside the updated guidance range, and Q4 Adjusted EBITDA rose 9% to $12.8 million even on lower revenue, so the cost discipline is real. The bigger item is FY2027 guidance: revenue of $263 million to $273 million and Adjusted EBITDA of $29 million to $34 million, with the midpoint implying roughly 9% EBITDA growth on about 2.5% revenue growth. That operating-leverage story rests on Enterprise North America deferred revenue, up 17% to $59.2 million, converting into reported revenue. Against that, cash fell to $13.3 million from $31.7 million a year earlier after $28.1 million of buybacks, so the $62.5 million undrawn credit facility is now the liquidity backstop. The China transition to a licensee trims about $2.0 million of FY2027 revenue but is not expected to materially affect Adjusted EBITDA.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FC was trading at $16.84 on NYSE in the Trade & Services sector, with a market capitalization of approximately $195.7M. The 52-week trading range was $11.16 to $26.81. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.